GBL
This article was originally published in The Tan Sheet
Executive Summary
Hillary J. Farias Date Rape Prevention Drug Act (HR 2130) passes the full House Commerce Committee by voice vote Aug. 5. The bill, which would classify both gamma butyrolactone and gamma hydroxybutyric acid as controlled substances, passed the Commerce/Health Subcommittee July 27 (1"The Tan Sheet" Aug. 2, p. 4). The bill should reach the House floor in the weeks following Labor Day. Sen. Spencer Abraham (R-Mich.) introduced companion legislation (S 1561) Aug. 5, which was referred to the Judiciary Committee
You may also be interested in...
GBL bill
House passes the Hillary J. Farias Date-Rape Prevention Drug Act Oct. 12 by a vote of 423-1. The bill (HR 2130) would classify both gamma butyrolactone and gamma hydroxybutyric acid as controlled substances; it passed the House Commerce Committee by voice vote Aug. 5 (1"The Tan Sheet" Aug. 16, In Brief). Companion legislation introduced in the Senate by Spencer Abraham (R-Mich.) is expected to be the subject of a hearing in the next 10 to 14 days. GBL, sold as a dietary supplement, has been the subject of several FDA warnings; GHB is under scrutiny as a "date rape" drug
GBL bill
House passes the Hillary J. Farias Date-Rape Prevention Drug Act Oct. 12 by a vote of 423-1. The bill (HR 2130) would classify both gamma butyrolactone and gamma hydroxybutyric acid as controlled substances; it passed the House Commerce Committee by voice vote Aug. 5 (1"The Tan Sheet" Aug. 16, In Brief). Companion legislation introduced in the Senate by Spencer Abraham (R-Mich.) is expected to be the subject of a hearing in the next 10 to 14 days. GBL, sold as a dietary supplement, has been the subject of several FDA warnings; GHB is under scrutiny as a "date rape" drug
GBL bill
House passes the Hillary J. Farias Date-Rape Prevention Drug Act Oct. 12 by a vote of 423-1. The bill (HR 2130) would classify both gamma butyrolactone and gamma hydroxybutyric acid as controlled substances; it passed the House Commerce Committee by voice vote Aug. 5 (1"The Tan Sheet" Aug. 16, In Brief). Companion legislation introduced in the Senate by Spencer Abraham (R-Mich.) is expected to be the subject of a hearing in the next 10 to 14 days. GBL, sold as a dietary supplement, has been the subject of several FDA warnings; GHB is under scrutiny as a "date rape" drug